ESK-001, a novel therapy for moderate to severe plaque psoriasis, had acceptable safety and efficacy outcomes at 12 weeks of treatment.

By week 68, PP-NRS scores decreased by 78.6% in the 30-mg dose group and 76.5% in the 60-mg group from baseline. Patients who switched from placebo showed reductions of 78.4% and 70.7% in PP-NRS ...

Results also showed that among patients with a baseline SI-NRS score of at least 4, a higher percentage of patients treated with roflumilast foam achieved SI-NRS success at week 8 (65.3% vs 30.3% ...

Aodifying your walking style may relieve the pain and slow the progression of knee osteoarthritis as effectively as commonly used medications, a recent study has found.

Outcomes measured included average numeric rating scale (NRS) score, median NRS score, maximum NRS score, normalized area under pain vs. time curve, number of pain scores greater than 4 in the ...

"Spine BioPharma’s trial of SB-01 fails to meet primary endpoint" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

The FDA has approved Tonmya (cyclobenzaprine hydrochloride sublingual tablets) for the treatment of fibromyalgia in adults.

GLP-1 RA therapy reduces hidradenitis suppurativa severity, flares, symptoms, and BMI in patients with hidradenitis ...

In the second sequence, researchers again observed a significantly reduced median dyspnea-NRS score with nasal high-flow at 50 L/minute vs. 0 L/minute (5 vs. 6; P < .01).